Global Antibiotics for Dogs and Cats Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Antibiotics for Dogs and Cats market size was valued at US$ 321 million in 2024 and is forecast to a readjusted size of USD 474 million by 2031 with a CAGR of 5.8% during review period.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 718%.

This report is a detailed and comprehensive analysis for global Antibiotics for Dogs and Cats market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Antibiotics for Dogs and Cats market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Antibiotics for Dogs and Cats market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Antibiotics for Dogs and Cats market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Antibiotics for Dogs and Cats market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Antibiotics for Dogs and Cats

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Antibiotics for Dogs and Cats market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Huvepharma, Merck & Co, Ceva Animal Health, Zoetis, Crystal Pharma, Afrivet, Elanco, Merck Animal Health, Merial, Bayer Animal Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Antibiotics for Dogs and Cats market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Tetracyclines
Penicillins
Sulfonamides
Macrolides
Aminoglycosides
Cephalosporins
Others

Market segment by Application
Cats
Dogs

Major players covered
Huvepharma
Merck & Co
Ceva Animal Health
Zoetis
Crystal Pharma
Afrivet
Elanco
Merck Animal Health
Merial
Bayer Animal Health
Virbac
Ceva
Boehringer Ingelheim
Vetoquinol
Phibro Animal Health
NCPC
LKPC

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Antibiotics for Dogs and Cats product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Antibiotics for Dogs and Cats, with price, sales quantity, revenue, and global market share of Antibiotics for Dogs and Cats from 2020 to 2025.

Chapter 3, the Antibiotics for Dogs and Cats competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Antibiotics for Dogs and Cats breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antibiotics for Dogs and Cats market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Antibiotics for Dogs and Cats.

Chapter 14 and 15, to describe Antibiotics for Dogs and Cats sales channel, distributors, customers, research findings and conclusion.